Gut microbiota composition in responders vs. non-responders with hepatocellular carcinoma under ICI therapy: a systematic review and meta-analysis - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparative Analysis of Gut Microbiome Profiles in Hepatocellular Carcinoma Patients Responding and Not Responding to Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis

  • By

  • Guo Lin

  • Bowei Huang

  • Shun Chen

  • Hangbin Zheng

  • Wenxin Huang

  • Juan Hu

  • Liangyi Zhou

  • Liwu Chen

  • September 9, 2026

Share

Original Source(s)

Gut microbiota composition in responders vs. non-responders with hepatocellular carcinoma under ICI therapy: a systematic review and meta-analysis

  • by Guo Lin, Bowei Huang, Shun Chen, Hangbin Zheng, Wenxin Huang, Juan Hu, Liangyi Zhou, Liwu Chen

  • September 9, 2026

Related Content

CD19 CAR T Therapy Tested in Refractory Rheumatoid Arthritis

Disease activity fell in all six participants in a phase I trial, with three achieving sustained drug-free remission during follow-up

  • September 8, 2026

  • 3 min
Dynamic clonal evolution of multiple bypass resistance mechanisms in EGFR-mutant lung adenocarcinoma: a case report

Correction: Defining post–colon capsule endoscopy colorectal cancer (pCCECRC)—an International Capsule Endoscopy Research (iCARE) group consensus statement